Z. Liu, I. Romero-Canelon, B. Qamar, J. M. Hearn, A. Habtemariam, N. P. E. Barry, A. M. Pizarro and P. J. Sadler (2013) Redox paradox: potent organoiridium anticancer agents use cellular antioxidants to generate reactive oxygen species (ROS). Angew. Chem. Int. Ed. (VIP) In Press.

Y. Fu, R. Soni, M. J. Romero, A. M. Pizarro, L. Salassa, G. J. Clarkson, J. M. Hearn, A. Habtemariam, M. Wills, and P. J. Sadler (2013) Mirror-image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity. Chem. Eur. J. In press

J. M. Hearn, I. Romero-Canelon, B. Qamar, Z. Liu, I. Hands-Portman and P. J. Sadler (2013) Organometallic iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting and apoptosis. ACS Chem. Biol. 8 (6): pp 1335–1343

I. Romero-Canelon, B. Qamar, J. M. Hearn and P. J. Sadler (2012) Overcoming platinum resistance: triggering the extrinsic apoptotic pathway. 11th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy (Conference paper)